QIM
RXII

Quantitative Investment Management’s GALENA BIOPHARMA INC COM RXII Stock Holding History

Quantitative Investment Management’s Portfolio RXII Stock Details RXII Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-33,200
Closed -$52K – 976
2015
Q3 		$52K Sell
33,200
-31,400
-49% -$49.2K ﹤0.01% 652
2015
Q2 		$109K Buy
+64,600
New +$109K 0.02% 415
2014
Q3 		– Sell
-15,700
Closed -$48K – 618
2014
Q2 		$48K Sell
15,700
-332,800
-95% -$1.02M 0.01% 441
2014
Q1 		$871K Buy
348,500
+315,200
+947% +$788K 0.04% 268
2013
Q4 		$165K Buy
+33,300
New +$165K 0.02% 529

Other funds holding RXII

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $3.03B AUM 104.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
BIM
BlackRock Investment Management Wilmington, Delaware $86.4B AUM 16.83% 1-Year Est. Return
TCIM
TIAA CREF Investment Management New York $141B AUM 14.18% 1-Year Est. Return